Thermo Fisher Scientific Inc. (TMO)

271.66
6.30 2.37
NYSE : Health Technology
Prev Close 265.36
Open 267.63
Day Low/High 266.20 / 273.27
52 Wk Low/High 202.83 / 282.98
Volume 1.74M
Avg Volume 1.57M
Exchange NYSE
Shares Outstanding 399.98M
Market Cap 104.69B
EPS 7.30
P/E Ratio 33.58
Div & Yield 0.76 (0.27%)

Latest News

Thermo Fisher Scientific To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference On May 14, 2019

Thermo Fisher Scientific To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference On May 14, 2019

WALTHAM, Mass., May 7, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Completes Acquisition Of Brammer Bio

Thermo Fisher Scientific Completes Acquisition Of Brammer Bio

WALTHAM, Mass., May 1, 2019 /PRNewswire/ --  Thermo Fisher Scientific Inc.

Thermo Fisher Scientific To Host Analyst Meeting

Thermo Fisher Scientific To Host Analyst Meeting

WALTHAM, Mass., April 29, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.

Netflix Taking a Knife to a Gunfight with Disney, Apple, Plus Bitcoin

Netflix Taking a Knife to a Gunfight with Disney, Apple, Plus Bitcoin

Bitcoin, the most famous of all crypto-currencies, has enjoyed something of a rebound of late.

Thermo Fisher Scientific Reports First Quarter 2019 Results

Thermo Fisher Scientific Reports First Quarter 2019 Results

WALTHAM, Mass., April 24, 2019 /PRNewswire/ --  Thermo Fisher Scientific Inc.

Keep Your Eye on the Oncology Sector Among Biotech Stocks

Keep Your Eye on the Oncology Sector Among Biotech Stocks

The myriad names in oncology have been the hottest area for acquisitions along with gene therapy.

Thermo Fisher Scientific To Hold Earnings Conference Call On Wednesday, April 24, 2019

Thermo Fisher Scientific To Hold Earnings Conference Call On Wednesday, April 24, 2019

WALTHAM, Mass., April 1, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.

What More Do They Want?: Cramer's 'Mad Money' Recap (Monday 3/25/19)

What More Do They Want?: Cramer's 'Mad Money' Recap (Monday 3/25/19)

Apple couldn't do much to hold back the bears today, but Jim Cramer says the company's services segment is the most important thing and he's more than happy with it.

Thermo Fisher to Buy Gene-Therapy Company Brammer Bio for $1.7 Billion

Thermo Fisher to Buy Gene-Therapy Company Brammer Bio for $1.7 Billion

Thermo Fisher Scientific reaches a deal to buy closely held Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies.

Apple, Mueller Report, Recession Signals and Uber - 5 Things You Must Know

Apple, Mueller Report, Recession Signals and Uber - 5 Things You Must Know

U.S. stock futures fall as last week's sharp selloff continues amid concerns over the strength of the world economy and the first inversion of the U.S. Treasury yield curve in more than a decade; the report from Special Counsel Robert Mueller finds the Trump campaign didn't conspire with Russia to swing the 2016 election; Apple is expected Monday to unveil a new subscription video service.

Thermo Fisher Scientific To Acquire Brammer Bio, A Leader In Viral Vector Manufacturing

Thermo Fisher Scientific To Acquire Brammer Bio, A Leader In Viral Vector Manufacturing

Significantly expands capabilities to support high-growth gene and cell therapy market

Thermo Fisher Scientific Innovations At Pittcon 2019 Enable Workflows Across Life Sciences, Applied And Industrial Markets

Thermo Fisher Scientific Innovations At Pittcon 2019 Enable Workflows Across Life Sciences, Applied And Industrial Markets

PHILADELPHIA, March 19, 2019 /PRNewswire/ --  Pittcon 2019 -- Thermo Fisher Scientific Inc.

Thermo Fisher Scientific To Invest $150 Million To Expand Pharma Services Capabilities

Thermo Fisher Scientific To Invest $150 Million To Expand Pharma Services Capabilities

Expansion projects will increase capacity to meet growing customer demand for biologics

Thermo Fisher Scientific To Present At The Barclays Global Healthcare Conference On March 13, 2019

Thermo Fisher Scientific To Present At The Barclays Global Healthcare Conference On March 13, 2019

WALTHAM, Mass., March 4, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Increases Quarterly Dividend

Thermo Fisher Scientific Increases Quarterly Dividend

WALTHAM, Mass., Feb.

Investing Ideas for Extraction and Vape

Investing Ideas for Extraction and Vape

Valens GroWorks gains traction in rapidly growing space.

Torque And Thermo Fisher Scientific Announce Collaboration To Build State-of-the-Art Facility To Manufacture Torque's Deep-Primed T Cell Immunotherapies

Torque And Thermo Fisher Scientific Announce Collaboration To Build State-of-the-Art Facility To Manufacture Torque's Deep-Primed T Cell Immunotherapies

-Thermo Fisher's Princeton, NJ facility to come online in 2019 to support clinical development of Torque's expanding cellular immunotherapy pipeline -

Why Huawei Matters, FOMC Decision, AAPL Results, Watching NOW: Market Recon

Why Huawei Matters, FOMC Decision, AAPL Results, Watching NOW: Market Recon

I think we can all agree that there will be no increase made to the Fed Funds Rate today.

Gatan Acquisition Requires Further UK Review

Gatan Acquisition Requires Further UK Review

WALTHAM, Mass. and SARASOTA, Fla.

Thermo Fisher Shows Super Relative Strength - Go Long or Add to Longs

Thermo Fisher Shows Super Relative Strength - Go Long or Add to Longs

Let's check the charts and indicators.

Putting the Markets in Focus: Cramer's 'Mad Money' Recap (Thursday 11/15/18)

Putting the Markets in Focus: Cramer's 'Mad Money' Recap (Thursday 11/15/18)

Jim Cramer says perception is determining how stocks trade right now -- and there's a lot of negativity.

BP, Arconic, Fiat Chrysler: 'Mad Money' Lightning Round

BP, Arconic, Fiat Chrysler: 'Mad Money' Lightning Round

Jim Cramer take a closer look at BP, Arconic, Fiat Chrysler, Qualcomm, Thermo Fisher, GameStop, Arena Pharmaceuticals and more.

Bad News Is Good News: Cramer's 'Mad Money' Recap (Thursday 11/8/18)

Bad News Is Good News: Cramer's 'Mad Money' Recap (Thursday 11/8/18)

Cramer said the recent selloff has been good for investors because it reset expectations. Here's what he thinks about energy and the Fed.

Emerson Electric, Arista Networks, Foot Locker: 'Mad Money' Lightning Round

Emerson Electric, Arista Networks, Foot Locker: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Emerson Electric, Arista Networks, Foot Locker, SailPoint Technologies, Crown Holdings, Idexx Laboratories and more.

TheStreet Quant Rating: A- (Buy)